Live Breaking News & Updates on Sierra oncology

Stay informed with the latest breaking news from Sierra oncology on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Sierra oncology and stay connected to the pulse of your community

GSK plc: An Undervalued Vaccine Behemoth That Is Resuming Growth; Buy (GSK)

GSK plc: An Undervalued Vaccine Behemoth That Is Resuming Growth; Buy (GSK)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

China , United-kingdom , British , Smithkline-beecham , Pfizer , Amgen , Glaxosmithkline-headquarters-in-brentford , Glaxo-wellcome , Sierra-oncology , Horizon-therapeutics , Prometheus-biosciences ,

Checkpoint Inhibitors Clinical Trial Pipeline Insights | 180+ Key Companies Investigating Their Lead Candidates to Improve the Treatment Space |

Checkpoint Inhibitors Clinical Trial Pipeline Insights | 180+ Key Companies Investigating Their Lead Candidates to Improve the Treatment Space |
medgadget.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medgadget.com Daily Mail and Mail on Sunday newspapers.

China , Sandeep-joshi , Immuneonco-biopharma , Akeso-biopharma , Serono-merck , Lyvgen-biopharma , Mereo-biopharma , Theravance-biopharma , Eucure-biopharma , Bristol-myers-squibb , Innovent-biologics , Lepu-biopharma

Blood Cancer Drugs Market Report 2023: Reveals Striking Growth Prospects with a Surge in R&D Activities

/PRNewswire/ -- The "Blood Cancer Drugs Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The latest market research...

United-states , Dublin , Ireland , America , Eli-lilly , Laura-wood , Amgen-inc , Ono-pharmaceutical-co , Company-inc , Abbvie-inc , Takeda-pharmaceutical-company , Menarini-group

MorphoSys: Positive Pelabresib Data Finally Unlocking Upside (NASDAQ:MOR)

MorphoSys: Positive Pelabresib Data Finally Unlocking Upside (NASDAQ:MOR)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Germany , Munich , Bayern , German , Biopharma-vonjo , Johnson-tremfya , Bristol-myers-squibb , European-medicines-agency , Constellation-pharmaceuticals , Nasdaq , Geron-corporation , Drug-administration

Ex-Celgene CEO takes the top job at TORL—Chutes & Ladders

Ex-Celgene CEO takes the top job at TORL—Chutes & Ladders
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

United-states , America , Deepika-jalota , Adi-hoess , Marc-fellous , Max-bayer , Molly-gibson , Daiichi-sankyo , Hans-moebius , Robert-califf , Paolo-martini , Julie-tierney

At JPM, Top GSK Cancer Executive Talks Drug Targets and Oncology Strategy

Though GSK divested much of its oncology assets to Novartis in 2015, the company has built it back through a internal R&D and business development deals. GSK Senior Vice President, Global Head of Oncology, R&D Hesham Abdullah explained the company’s evolving cancer strategy in an interview during the J.P. Morgan Healthcare Conference in San Francisco.

United-states , San-francisco , California , American , Johnson-darzalex , Ideaya-biosciences , Hansoh-adcs , Hansoh-pharma , Hesham-abdullah , Memorial-sloan-kettering-cancer-center , American-society-of-clinical-oncology , Novartis

Vera Therapeutics Announces Appointment of Industry

BRISBANE, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company developing and...

Stanford-university , California , United-states , Brisbane , Queensland , Australia , Joyce-allaire , Orionis-biosciences , Celia-lin , Marshall-fordyce , Williamd-turner , Mari-purpura

Vera Therapeutics, Inc. Announces Executive Changes

Vera Therapeutics, Inc. announced the appointments of two industry veterans to help lead the development of the company?s drug programs including its late-stage product candidate, atacicept, to treat...

California , United-states , Stanford-university , Williamd-turner , Robertm-brenner , Orionis-biosciences , Celia-lin , Albert-einstein-college-of-medicine , Vera-therapeutics-inc , Astrazeneca , Regulatory-affairs , California-state-university-at-long-beach

Oncology Drugs Market Size, Share & Growth Analysis, [2030]

Oncology Drugs Market Size, Share & Growth Analysis, [2030]
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

Pune , Maharashtra , India , Switzerland , United-states , California , United-kingdom , America , Asia-pacific , Eli-lilly , Key-industry-development , Pfizer-inc

Geron (GERN) Stock: Lancet Publication Narrowly Makes Bull Case

Geron (GERN) Stock: Lancet Publication Narrowly Makes Bull Case
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Germany , Foster-city , California , United-states , Munich , Bayern , Bristol-myers-squibb , European-hematology-association , Geron-corporation , International-prognostic-scoring-system , Drug-agency , Red-blood-cells